Bd Phoenix Automated Microbiology System-Amoxicillin-Clavulanate(Gp) 0.25/0.12 -32/16 Ug/Ml
by Becton, Dickinson & CO 510(k)
Active
510(k) K061673
Overview
The BD Phoenix Automated Microbiology System Amoxicillin-Clavulanate (GP) 0.25/0.12 - 32/16 µg/mL is an automated system for antimicrobial susceptibility testing. It is designed to rapidly identify and test the in vitro susceptibility of aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria from pure cultures of human origin. The system falls under the classification of an automated antimicrobial susceptibility test device, enabling streamlined microbiological analysis in clinical settings.
This device is intended for use in microbiology laboratories and operates as a reusable instrument. It is not sterile and is supplied as part of a broader automated microbiology system, requiring proper calibration and maintenance. The system adheres to FDA 510(k) clearance under the classification of Class II medical devices, with regulatory oversight under the code 866.1645. The system is not MRI-safe and must be stored according to manufacturer guidelines to ensure accurate and reliable performance.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK061673 | Date28 Jul 2006 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 6 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LON
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1645
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent